Frontlight ResearchEarly access
Trial site
Nantong First People's Hospital
- 11running trials
- 5closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease2 trials
- Type 2 diabetes2 trials
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Gestational diabetes1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- Osteoporosis1 trial
- Parkinson disease1 trial
- Rheumatoid arthritis1 trial
- and 2 more
- Phase
- Phase 34 trials
- Phase 43 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Completed5 trials
- Not yet recruiting5 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- First Affiliated Hospital of Zhejiang University2 trials
- Capital Medical University1 trial
- Eli Lilly and Company1 trial
- Fudan University1 trial
- Guangdong Provincial People's Hospital1 trial
- and 10 more
Running trials
Recruiting
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Not yet recruiting
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
The Role of Early Nursing Intervention in the High-risk Population of Gestational Diabetes
Recruiting
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
Not yet recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Coronary artery disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Rheumatoid arthritis1 recruiting
- Triple-negative breast cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026